Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

SALMON Pharma GmbH — Vallon Pharmaceuticals, Inc. insider: 1 transactions · InsiderLens

Home / Insiders / SALMON Pharma GmbH

SALMON Pharma GmbH

10% owner at Vallon Pharmaceuticals, Inc. · on record since Feb 12, 2021

Insider trading activity of SALMON Pharma GmbH

Transactions on record: 1; since Feb 12, 2021

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Feb 12, 2021

Figures computed from official regulatory filings — methodology.

Companies where SALMON Pharma GmbH has traded

Vallon Pharmaceuticals, Inc.1 tx · $301.2K · Feb 12, 2021

Track record of SALMON Pharma GmbH

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of SALMON Pharma GmbH

Co-insiders of SALMON Pharma GmbH

Agro AlbertVallon Pharmaceuticals, Inc.
Ammer RichardVallon Pharmaceuticals, Inc.
Arcturus Therapeutics Holdings Inc.Vallon Pharmaceuticals, Inc.
Baker David CharlesVallon Pharmaceuticals, Inc.
Chaturvedi VipinVallon Pharmaceuticals, Inc.
Chhabra MeenuVallon Pharmaceuticals, Inc.
Hertz Walter MarcVallon Pharmaceuticals, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Kelly Leanne M.Vallon Pharmaceuticals, Inc.

Levi OfirVallon Pharmaceuticals, Inc.

Payne Joseph EVallon Pharmaceuticals, Inc.

Rongen RoelofVallon Pharmaceuticals, Inc.

SIMPSON CAMILLA VVallon Pharmaceuticals, Inc.

Szekeres David LeslieVallon Pharmaceuticals, Inc.

Thorell MarellaVallon Pharmaceuticals, Inc.

Toren PennyVallon Pharmaceuticals, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
Vallon Pharmaceuticals, Inc.	Feb 12, 2021	Other	47,063	6.40 USD	$301.2K	SEC